COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials

<p><span data-sheets-value= "{"1":2,"2":"<p>As COVID-19 infection rates again spike around the nation, this week, we're looking at two recent studies focused on COVID-19 and cancer. The first describes the rate of infection with the virus among asymptomatic patients with cancer undergoing active treatment for their solid tumors. The second explores how the ongoing pandemic is affecting the way patients with cancer choose to participate in clinical trials.</p><p><b>Coverage of stories discussed this week on ascopost.com:</b></p><p><a href=\"https://ascopost.com/news/november-2020/serial-covid-19-screening-in-asymptomatic-patients-receiving-treatment-for-cancer/\">Serial COVID-19 Screening in Asymptomatic Patients Receiving Treatment for Cancer</a></p><p><a href=\"https://ascopost.com/news/november-2020/survey-finds-patients-with-cancer-may-be-less-likely-to-enroll-in-clinical-trials-during-the-covid-19-pandemic/\">Survey Finds Patients With Cancer May Be Less Likely to Enroll in Clinica...